2026-01-04 - Analysis Report
Okay, here's a comprehensive analysis of UnitedHealth Group (UNH) based on the provided data.

**0. Overview**

We'll start with simple numerical summaries, then build up to a more comprehensive analysis.

**1. Return Rate Comparison**

*   **Ticker:** UNH
*   **Company Overview:** UnitedHealth Group is a diversified healthcare company providing a wide range of products and services, such as health insurance.
*   **UNH Cumulative Return:** -20.24%
*   **S&P 500 (VOO) Cumulative Return:** 91.00%
*   **Divergence:**
    *   Maximum: 29.8
    *   Minimum: -124.6
    *   Current: -113.3
    *   Relative Divergence: 7.3

**Analysis:**

UNH has significantly underperformed the S&P 500. The divergence of -113.3 indicates a large performance gap. A relative divergence of 7.3 suggests this divergence is near the lower end of its historical range (close to its worst divergence relative to VOO).  The stock is currently severely underperforming.

**Alpha, Beta Analysis**

| Year       | CAGR    | MDD     | Alpha    | Beta | Cap(B) |
|------------|---------|---------|----------|------|--------|
| 2016-2018  | 22.0%   | 18.6%   | 19.0%    | 0.9  | 225.7  |
| 2017-2019  | 27.0%   | 18.6%   | 10.0%    | 0.9  | 266.3  |
| 2018-2020  | -41.0%  | 32.5%   | -62.0%   | 1.1  | 317.7  |
| 2019-2021  | 16.0%   | 32.5%   | -27.0%   | 1.1  | 454.9  |
| 2020-2022  | 0.0%    | 31.5%   | 2.0%     | 0.9  | 480.3  |
| 2021-2023  | 23.0%   | 13.4%   | 23.0%    | 0.5  | 476.9  |
| 2022-2024  | -24.0%  | 23.1%   | -44.0%   | 0.4  | 458.2  |
| 2023-2025  | -55.0%  | 58.5%   | -118.0%  | 0.3  | 299.0  |

*   **CAGR (Compound Annual Growth Rate):** Fluctuates significantly, showing periods of strong growth and significant declines. The recent period (2023-2025) has a very negative CAGR.
*   **MDD (Maximum Drawdown):** Indicates the largest peak-to-trough decline during the period. The high MDD values, especially in recent years, highlight increased volatility.
*   **Alpha:** Measures the investment's performance relative to a benchmark (presumably the S&P 500).  Negative Alpha values indicate underperformance compared to the benchmark. Alpha has been strongly negative recently.
*   **Beta:** Measures the investment's volatility relative to the market. A Beta around 1 suggests volatility similar to the market. Beta has decreased to 0.3 recently.
*   **Cap(B) (Market Capitalization in Billions):** Shows the company's size.  Market cap has declined significantly in the recent 2023-2025 period.

**Analysis:**

*   The Alpha/Beta analysis reveals a concerning trend.  While UNH showed periods of outperformance in the past (positive Alpha), recent years are characterized by substantial underperformance (negative Alpha).
*   The decreasing Beta suggests UNH has become less correlated with the overall market.
*   The recent large Maximum Drawdown (MDD) and significant CAGR decline shows major issues.
*   The recent decline in market capitalization also suggests that the company's value has decreased significantly.

**2. Recent Stock Price Fluctuations**

*   **Close:** 336.40
*   **Last-market:** price: 336.4, previousClose: 330.11, change: 1.91
*   **5-day SMA:** 331.89
*   **20-day SMA:** 330.90
*   **60-day SMA:** 337.34

**Analysis:**

*   The current price is slightly above the 5-day and 20-day Simple Moving Averages (SMAs) but below the 60-day SMA. This suggests a short-term upward trend but potential resistance at the 60-day SMA level.
*   The price change indicates a recent increase in stock price.

**3. RSI, PPO, and Expected Return**

*   **MRI (Market Risk Indicator):** 0.8 (Medium Investment)
*   **RSI (Relative Strength Index):** 49.62
*   **PPO (Percentage Price Oscillator):** 0.1859
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (2 shares - Safe - MRI:0.80) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2026-01-02)
*   **Recent Relative Divergence Change:** 1.9 (+): Short-term increase
*   **Expected Return (%):** -285.6

**Analysis:**

*   **MRI:** The MRI suggests a "Medium Investment" recommendation, indicating a moderate level of risk.
*   **RSI:** An RSI of 49.62 is neutral, indicating neither overbought nor oversold conditions.
*   **PPO:** The PPO being slightly positive also suggests that the short-term moving average is trending slightly higher than the long-term moving average.
*   **Hybrid Signal:**  The signal suggests buying 90% of cash, indicating a bullish stance based on the current indicators and MRI.
*   **Recent Relative Divergence Change:** The recent increase in relative divergence suggests a short-term upward trend.
*   **Expected Return:** The massively negative expected return of -285.6% is extremely concerning. It suggests a highly unfavorable outlook for long-term investment compared to the S&P 500.

**4. Recent News & Significant Events**

*   **UnitedHealth Group Stock (UNH) Opinions on Recent Price Surge and 2026 Outlook:** Focuses on the stock's recent price increase and potential future performance.
*   **UnitedHealth Group (UNH) Prepares for Operational Changes Following External Audit:** Indicates potential adjustments to business operations based on audit findings.
*   **3 Risks That Can Make UnitedHealth Stock Unattractive:** Highlights potential downsides and challenges facing the company.
*   **UnitedHealth: Valuation Is Reset, Bull Case Is Still Standing Tall:** Suggests a reassessment of the stock's value but maintains a positive long-term outlook.
*   **UnitedHealth (UNH) stock closes up 1.9% to start 2026 as earnings loom:** Notes the stock's recent performance and the upcoming earnings announcement.
*   **Olstein Capital Management L.P. Sells 8,500 Shares of UnitedHealth Group Incorporated $UNH:** Reports a sale of shares by an institutional investor, which could indicate a lack of confidence in the stock.

**Analysis:**

The news is mixed. There is positive sentiment regarding recent price movements and a "bull case" valuation, but there are also concerns about risks, operational changes, and institutional selling. The upcoming earnings announcement will likely be a crucial catalyst for the stock.

**4-2. Analyst Opinions**

*   **Target Price (avg/high/low):** 392.24 / 440.00 / 280.00

**Analysis:**

Analysts' average target price of $392.24 suggests potential upside from the current price. However, there's a wide range between the high and low target prices, indicating uncertainty.

**5. Recent Earnings Analysis**

| 날짜       | EPS   | 매출          |
|------------|-------|---------------|
| 2025-10-28 | 2.59  | 113.16 B$     |
| 2025-08-11 | 3.76  | 111.62 B$     |
| 2025-05-07 | 6.9   | 109.58 B$     |
| 2024-11-04 | 6.56  | 100.82 B$     |
| 2025-10-28 | 6.56  | 100.82 B$     |

**Analysis:**

*   Revenue has generally been increasing over the past few quarters.
*   EPS (Earnings Per Share) has fluctuated.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30   | $113.16B   | 18.24%        |
| 2025-06-30   | $111.62B   | 17.93%        |
| 2025-03-31   | $109.58B   | 21.70%        |
| 2024-12-31   | $100.81B   | 21.14%        |
| 2024-09-30   | $100.82B   | 22.84%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE    |
|--------------|------------|--------|
| 2025-09-30   | $95.79B   | 2.45%  |
| 2025-06-30   | $94.72B   | 3.60%  |
| 2025-03-31   | $95.04B   | 6.62%  |
| 2024-12-31   | $92.66B   | 5.98%  |
| 2024-09-30   | $94.53B   | 6.41%  |

**Analysis:**

*   Revenue has shown consistent growth.
*   Profit Margins have fluctuated but remain relatively strong.
*   Equity has generally been increasing.
*   ROE (Return on Equity) has decreased significantly in recent quarters.

**7. Comprehensive Analysis**

Based on all the provided data, here's a summary:

*   **Underperformance:** UNH has significantly underperformed the S&P 500, and the divergence is near its historical worst.
*   **Volatility and Risk:** Recent performance exhibits high volatility and significant drawdowns, as reflected in the negative Alpha, decreasing Beta, and large MDD.
*   **Mixed Signals:** Technical indicators offer mixed signals. The MRI suggests medium risk, while the Hybrid Signal indicates a buy recommendation. However, the expected return is alarmingly negative.
*   **Mixed News:** Recent news articles present a mixed picture, with positive articles about price increases and valuation but also articles highlighting risks and operational changes.
*   **Analyst Uncertainty:** Analyst target prices suggest potential upside, but the wide range reflects uncertainty.
*   **Financial Health:** While revenue has been growing, profit margins and ROE have fluctuated or decreased in recent quarters.

**Overall Conclusion:**

The data paints a concerning picture for UNH.  While the company has shown revenue growth, the severe underperformance compared to the S&P 500, high volatility, negative expected return, and mixed news create a high-risk profile. The recent decrease in ROE is a significant red flag.  While analysts see some upside potential, the risks appear to outweigh the rewards based on this information.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.